Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.037 | 0.6 |
mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |